Befimmo, DSM, Nyrstar, Vopak: Benelux Equity Market Preview

The following companies may have unusual price changes in Benelux markets. Stock symbols are in parentheses, and prices are from the previous close.

The AEX-Index (AEX) in Amsterdam advanced 0.54, or 0.2 percent, to 359.55. Belgium’s Bel20 Index rose 20.55, or 0.8 percent, to 2,748.22. Luxembourg’s LuxX Index fell 0.2 percent to 1,412.56.

Dutch stocks:

CSM (CSM) NV: The world’s largest maker of bakery ingredients may report first-quarter sales of 725 million euros ($1.06 billion), according to the average estimate of three analysts surveyed by Bloomberg. CSM dropped 0.4 percent to 25.81 euros.

Royal DSM NV (DSM NA): The world’s largest vitamin maker may report first-quarter net income of 127 million euros, according to the average estimate of four analysts surveyed by Bloomberg. DSM dropped 0.2 percent to 43.42 euros.

Royal Vopak NV (VPK NA): The world’s biggest chemical and oil storage company is scheduled to give a first-quarter trading update. Vopak retreated 0.1 percent to 33.35 euros.

Belgian stocks:

Befimmo SCA (BEFB BB): Belgium’s second-biggest real-estate investment fund said it sold 162 million euros of 4.5 percent six-year bonds in a public offering to individual investors. Befimmo increased 0.8 percent to 61.47 euros.

Nyrstar (NYR) NV: The world’s largest zinc producer gives a first-quarter trading update before the start of trading. Nyrstar dropped 0.3 percent to 9.59 euros.

PinguinLutosa (PIN) NV: Europe’s second-largest producer of frozen vegetables said first-quarter sales increased 4.5 percent to 118.6 million euros. PinguinLutosa gained 0.9 percent to 10.24 euros.

To contact the reporters on this story: John Martens in Brussels at; Fred Pals in Amsterdam at

To contact the editors responsible for this story: Angela Cullen at; Andrew Rummer at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.